Comparison of tumour markers in induced sputum and serum

B. Ozkan, C. Simsek, F. Okten, T. Eryilmaz (Ankara, Turkey)

Source: Annual Congress 2004 - Molecular biology and tumoral markers
Session: Molecular biology and tumoral markers
Session type: Thematic Poster Session
Number: 585

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Ozkan, C. Simsek, F. Okten, T. Eryilmaz (Ankara, Turkey). Comparison of tumour markers in induced sputum and serum. Eur Respir J 2004; 24: Suppl. 48, 585

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CEA levels in the serum and induced sputum of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005

Relationship between total IgE in induced sputum and serum
Source: Eur Respir J 2002; 20: Suppl. 38, 509s
Year: 2002

Evaluation of serum tumour markers in the lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 268s
Year: 2002

Lack of correlation between BAL and induced sputum cell counts
Source: Eur Respir J 2001; 18: Suppl. 33, 508s
Year: 2001

Comparative evaluation of the diagnostic value of serum tumor markers versus those identified in bronchial lavage fluid in patients with histologically confirmed bronchial carcinoma
Source: Eur Respir J 2003; 22: Suppl. 45, 256s
Year: 2003

Can high levels of serum tumor markers be useful in predicting the histologic type of lung cancer?
Source: Eur Respir J 2004; 24: Suppl. 48, 77s
Year: 2004

Comparison of differential cell counts and interleukin-8 levels in bronchoalveolar lavage and induced sputum from lung transplant recipients
Source: Eur Respir J 2003; 22: Suppl. 45, 201s
Year: 2003

Simultaneous analysis of sputum and serum biomarkers in adult asthma
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019

Tumor markers in bronchial secretions and serum in patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 76s
Year: 2004

Comparison of induced and spontaneous sputum in the diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 64s
Year: 2001

Elevation of serum tumor markers in patients with interstitial lung disease
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Comparison of the serum soluble IL-2 receptor levels in the differential diagnosis of pulmonary tuberculosis and lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 475s
Year: 2001

Increased activin-a expression in serum, BAL and bronchial tissue of asthmatic patients
Source: Annual Congress 2009 - Novel approaches in asthma
Year: 2009


The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL
Source: Eur Respir J 2005; 26: Suppl. 49, 298s
Year: 2005

Effect of saliva contamination on induced sputum cell counts, IL-8 and eosinophil cationic protein levels
Source: Eur Respir J 2004; 23: 759-762
Year: 2004



Serum tumor markers in lung cancer patients
Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies
Year: 2007


Expression of selected surface markers on macrophages in induced sputum from patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003